Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.56 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,090
Open 28.56
Bid (Size) 28.51 (1)
Ask (Size) 28.55 (2)
Prev. Close 28.56
Today's Range 28.56 - 28.56
52wk Range 25.20 - 34.62
Shares Outstanding 5,606,688,356
Dividend Yield 5.74%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 No-Brainer Dividend Stocks With Yields Above 5% You Can Buy Now and Hold at Least a Decade
It's not hard to see how these well-seasoned businesses could deliver heaps of passive income to patient investors. 
Via The Motley Fool
3 No-Brainer Dividend Stocks to Buy in September
These stocks pay great dividends and could be long-term winners. 
Via The Motley Fool

Performance

YTD
-3.94%
-3.94%
1 Month
+0.04%
+0.04%
3 Month
+1.75%
+1.75%
6 Month
+0.67%
+0.67%
1 Year
-15.85%
-15.85%

More News

Read More
Bicycle Therapeutics' Lead Cancer Candidate's Has High-Opportunity, Analyst Initiates With Bullish Tone
Via Benzinga
FDA Battles Backlog of Drug Factory Inspections Since COVID-19
Via Benzinga
Exposures Product Safety
What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday?
Via Benzinga
Exposures Product Safety
A Few Years From Now, You'll Wish You Had Bought This Undervalued Stock
Via The Motley Fool
Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern
Via Benzinga
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Walgreens Boots Alliance Fell Another 22% in August
Via The Motley Fool
Ascendis Pharma Faces Challenges With Skytrofa And Yorvipath Pricing: Analysts Weigh In
Via Benzinga
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031
Via FinancialNewsMedia
Exposures COVID-19
3 Bargain-Priced Growth Stocks for Fall 2024
Via MarketBeat
Topics Economy
Exposures COVID-19 Economy
Therma Bright Congratulates John Patton, PhD of InStatin on Receiving the Prestigious Charles G. Thiel Award
Via Newsfile
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031
From FN Media Group LLC
Via GlobeNewswire
UK, Taiwan Approve Moderna's Updated COVID-19 Shot
Via Benzinga
Exposures COVID-19
Pfizer And Valneva Partnered Lyme Disease Vaccine Shows Effectiveness As Booster Shot In Mid-Stage Study
Via Benzinga
Vaxcyte, Shoals Technologies, Polestar Automotive, Applied Optoelectronics And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Bacterial Infections Vaccine Developer Vaxcyte's Pneumococcal Shot Shows Promise in Mid-Stage Trial, Stock Shoots Higher
Via Benzinga
Vaxcyte Catapults 34% As It Looks To Take On Pfizer In A $10 Billion Market
Via Investor's Business Daily
Why Is BridgeBio Pharma Stock Trading Higher On Friday?
Via Benzinga
Alnylam Pharmaceuticals Stock Falls After Detailed Vutrisiran Data For A Condition With Stiff Heart Muscles
Via Benzinga
Alnylam Plummets, Reversing 50% Gain This Year, As Pfizer Rival Lags Expectations
Via Investor's Business Daily
2 Incredibly Cheap Growth Stocks to Buy Now
Via The Motley Fool
2 Incredibly Cheap Healthcare Stocks to Buy Now
Via The Motley Fool
The 9 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.